Clinical Trial Update: Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive or Exposed to BCG Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating intravesical chemotherapy in combination with systemic pembrolizumab for non-muscle-invasive bladder cancer unresponsive to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: BLATAM | Conditions: Non Muscle Invasive Bladder Cancer | Phase 2 | Status: NOT_YET_RECRUITING